Key statistics
As of last trade Hikma Pharmaceuticals PLC (HIK:LSE) traded at 1,967.00, -11.48% below its 52-week high of 2,222.00, set on Aug 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1,958.00 |
---|---|
High | 1,972.00 |
Low | 1,950.00 |
Bid | 1,967.00 |
Offer | 1,968.00 |
Previous close | 1,959.00 |
Average volume | 471.54k |
---|---|
Shares outstanding | 221.89m |
Free float | 153.95m |
P/E (TTM) | 28.74 |
Market cap | 4.28bn GBP |
EPS (TTM) | 0.6712 GBP |
Annual div (ADY) | 57.03 GBX |
---|---|
Annual div yield (ADY) | 2.91% |
Div ex-date | Mar 21 2024 |
Div pay-date | May 03 2024 |
Data delayed at least 20 minutes, as of Jun 04 2024 14:01 BST.
More ▼
Investors Chronicle View
The last IC recommendation on Hikma Pharmaceuticals PLC shares was Hold at 2,081.00 on 22 Feb 2024Read the full article